DE3772460D1 - Pharmazeutische zubereitung fuer eine parenterale verabreichung, die calcitonin als wirkstoff enthaelt. - Google Patents

Pharmazeutische zubereitung fuer eine parenterale verabreichung, die calcitonin als wirkstoff enthaelt.

Info

Publication number
DE3772460D1
DE3772460D1 DE8787108063T DE3772460T DE3772460D1 DE 3772460 D1 DE3772460 D1 DE 3772460D1 DE 8787108063 T DE8787108063 T DE 8787108063T DE 3772460 T DE3772460 T DE 3772460T DE 3772460 D1 DE3772460 D1 DE 3772460D1
Authority
DE
Germany
Prior art keywords
parenteral administration
active substance
pharmaceutical preparation
administration containing
containing calcitonin
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE8787108063T
Other languages
English (en)
Inventor
Filippo Lattanzi
Riccardo Vanni
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Sclavo SpA
Original Assignee
Sclavo SpA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sclavo SpA filed Critical Sclavo SpA
Application granted granted Critical
Publication of DE3772460D1 publication Critical patent/DE3772460D1/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/19—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles lyophilised, i.e. freeze-dried, solutions or dispersions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22—Hormones
    • A61K38/23—Calcitonins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/42—Proteins; Polypeptides; Degradation products thereof; Derivatives thereof, e.g. albumin, gelatin or zein
DE8787108063T 1986-06-20 1987-06-04 Pharmazeutische zubereitung fuer eine parenterale verabreichung, die calcitonin als wirkstoff enthaelt. Expired - Fee Related DE3772460D1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IT20865/86A IT1204400B (it) 1986-06-20 1986-06-20 Composizioni farmaceutiche contenente una calcitonina

Publications (1)

Publication Number Publication Date
DE3772460D1 true DE3772460D1 (de) 1991-10-02

Family

ID=11173243

Family Applications (1)

Application Number Title Priority Date Filing Date
DE8787108063T Expired - Fee Related DE3772460D1 (de) 1986-06-20 1987-06-04 Pharmazeutische zubereitung fuer eine parenterale verabreichung, die calcitonin als wirkstoff enthaelt.

Country Status (9)

Country Link
US (1) US5310727A (de)
EP (1) EP0249811B1 (de)
JP (1) JPS635028A (de)
AT (1) ATE66615T1 (de)
CA (1) CA1289071C (de)
DE (1) DE3772460D1 (de)
ES (1) ES2051709T3 (de)
GR (1) GR3002765T3 (de)
IT (1) IT1204400B (de)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2514249B2 (ja) * 1989-05-23 1996-07-10 帝人株式会社 安定化されたカルシトニン類医薬組成物
JPH078804B2 (ja) * 1990-08-28 1995-02-01 三菱化学株式会社 副腎皮質刺激ホルモン放出因子含有製剤
US5580856A (en) * 1994-07-15 1996-12-03 Prestrelski; Steven J. Formulation of a reconstituted protein, and method and kit for the production thereof
JPH0827018A (ja) * 1994-07-22 1996-01-30 Sanwa Kagaku Kenkyusho Co Ltd 生理活性ペプチド又は蛋白質を含有する薬剤組成物
IT1282374B1 (it) * 1996-01-31 1998-03-20 Therapicon Srl Composizioni farmaceutiche parenterali a base di calcitonine sintetiche a ph controllato con basso indice di dolorosita'
US5912014A (en) * 1996-03-15 1999-06-15 Unigene Laboratories, Inc. Oral salmon calcitonin pharmaceutical products
AU783952B2 (en) 2000-02-04 2006-01-05 Unigene Laboratories, Inc. Nasal calcitonin formulations
JP2003530839A (ja) * 2000-04-12 2003-10-21 プリンシピア ファーマスーティカル コーポレイション アルブミン融合タンパク質
US8088734B2 (en) * 2003-01-21 2012-01-03 Unigene Laboratories Inc. Oral delivery of peptides
US10342239B2 (en) * 2017-03-31 2019-07-09 George Pul Filled dough producing apparatus

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
USRE32347E (en) * 1972-05-15 1987-02-03 Ciba-Geigy Corp. Hypocalcaemic peptides and process for their manufacture
US4241051A (en) * 1977-11-04 1980-12-23 Christie Robert B Calcitonin
US4338335A (en) * 1980-02-05 1982-07-06 Merck & Co., Inc. Vaccine stabilizer containing L-glutamic acid and L-arginine
US4659696A (en) * 1982-04-30 1987-04-21 Takeda Chemical Industries, Ltd. Pharmaceutical composition and its nasal or vaginal use
JPS59163313A (ja) * 1983-03-09 1984-09-14 Teijin Ltd 経鼻投与用ペプチドホルモン類組成物
US4514331A (en) * 1983-06-29 1985-04-30 University Patents, Inc. Peptide hormones with calcitonin-like activity
JPS60193925A (ja) * 1984-03-13 1985-10-02 Chemo Sero Therapeut Res Inst 凍結乾燥製剤化ワクチン

Also Published As

Publication number Publication date
IT8620865A0 (it) 1986-06-20
ES2051709T3 (es) 1994-07-01
IT1204400B (it) 1989-03-01
CA1289071C (en) 1991-09-17
US5310727A (en) 1994-05-10
EP0249811A1 (de) 1987-12-23
JPS635028A (ja) 1988-01-11
EP0249811B1 (de) 1991-08-28
GR3002765T3 (en) 1993-01-25
ATE66615T1 (de) 1991-09-15

Similar Documents

Publication Publication Date Title
ES2069582T3 (es) Nucleosidos terapeuticos.
CA2093806A1 (en) Method of treating or preventing type 1 diabetes by oral administration of insulin
DK395689A (da) Pharmaceutisk tilberedning til behandling af diabetes mellitus
DE69233413D1 (de) Ein physiologisch wirksames Polypeptid enthaltende pharmazeutische Zusammensetzung
NO842290L (no) Fremgangsmaate for fremstilling av preparater inneholdende oralt antidiabetisk aktive stoffer
MX171191B (es) Composiciones farmaceuticas de glipizida
ES2051920T3 (es) Una composicion farmaceutica y su procedimiento de preparacion.
ATE76747T1 (de) Levodopa-methyl-ester enthaltende pharmazeutische zusammensetzungen, ihre herstellung und therapeutische verwendungen.
NO168629C (no) Fremgangsmaate for fremstilling av oralt administrerbare, antidiabetisk virkende preparater
NO174412C (no) Fremgangsmåte for fremstilling av en farmasöytisk formulering med programmert frigjöring for oral anvendelse
SE8804629D0 (sv) New therapeutically active compounds
BR9401199A (pt) Preparados de medicamentos, processo para a preparação de um preparado de medicamento, processo para a preparação de uma formulação de medicamento.
ATE66615T1 (de) Pharmazeutische zubereitung fuer eine parenterale verabreichung, die calcitonin als wirkstoff enthaelt.
DE3875108T2 (de) Physiologisch aktives polypeptid und pharmazeutische komposition.
BE1000722A4 (fr) Compositions pharmaceutiques de polypeptides adaptees a la resorption gastro-intestinale.
MC2025A1 (fr) Medicament contenant de l'azelastine et capable de liberer celle-ci de facon controlee
NO901128D0 (no) Fremgangsmaate ved fremstilling av et transdermalt terapeutisk system med trinnvis virkestoffavgivelse og anvendelsefor lokal eller systemisk virkestoffadministrering.
JPS5576816A (en) Drug for medicinal fatty liver
US5183665A (en) Composition for percutaneous administration and method for enhancing percutaneous absorption of a physiologically active ingredient empolying the same
ES512748A0 (es) "procedimiento para la preparacion de comprimidos a base del antibiotico fosfomicina".
DK493887A (da) Buccal formulering
DK0560207T3 (da) Præparat til oral anvendelse baseret på ibuprofen
ITRM910038A1 (it) Composizioni farmaceutiche aventi come principio attivo calcitonina da somministrarsi per via intranasale.
RU94001686A (ru) Иммуномодулирующее лекарственное средство

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee